Work

TREGCHECK 102: A study of tagmokitug (CHS-114) in combination with toripalimab and/or other treatments in participants with advanced solid tumors.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.tps2689

Authors: Dani Ran Castillo, Li-Yuan Bai, Hsin-Chen Lin, Jonathan Mizrahi, Meredith Pelster, Narendiran Rajasekaran, Theresa LaVallee, Hong Tang, Varun N. Kapoor, Subaweerage Dias, Yelena Y. Janjigian

Institutions: City Of Hope National Medical Center, City of Hope, China Medical University Hospital, Taichung Veterans General Hospital, Ochsner Medical Center, Sarah Cannon, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162686789

Cites:

Cited by:

Related to: